论文部分内容阅读
【案情简介】1997年8月21日,甘肃省经贸委向省政府呈送了《关于“康灵片”新药证书署名问题的意见》的报告,针对兰州工业资源研究所要独占“康灵片”新药证书上的署名的情况,提出在国家卫生部将颁发的“康灵片”新药证书上的署名,应由兰州工业资源研究所与平凉制药厂两家共同署名的意见,并建议省政府采取措施协调省卫生厅致函卫生部。
【Brief introduction of the case】 On August 21, 1997, Gansu Provincial Economic and Trade Commission presented the report of “Opinions on the Issue of the Signature of New Drug Certificate” to the provincial government on the basis of “Opinion on the Issue of the Signature of New Drug Certificate”. For the Lanzhou Institute of Industrial Resources, Film “new drug certificate signed by the state proposed in the Ministry of Health will be issued ” Kangling film "new drug certificate signature should be Lanzhou Institute of Industrial Resources and Pingliang pharmaceutical factory jointly signed the two views, And recommended that the provincial government take measures to coordinate the provincial health department wrote a letter to the Ministry of Health.